Australia's Leading Ophthalmic Magazine Since 1975

     Free Sign Up     

Australia's Leading Ophthalmic Magazine Since 1975

     Free Sign Up     

Search Results - News, July 2016

your search of 'News, July 2016' has 20 results.

sort by  Recent ▼
showing 1 - 12 of 20 results   

Eye disease researchers recognised for research excellence

Two eye disease researchers have received top honours from the National Health and Medical Research Centre (NHMRC). Read more »

Essilor competition targets vision-care innovation

Essilor International has launched a competition designed to encourage the development of innovative eye-care solutions. Read more »

Contact lens manufacturer studies myopia control in children

CooperVision is studying how the progression of myopia can be controlled in children through the use of daily disposable contact lenses. Read more »

Healthcare providers' registration standards revised

National registration boards regulating most Australian-registered healthcare practitioners, including optometrists and medical practitioners, have revised their registration standards. Read more »

CXL system gains additional indication

A system that is said to be the first and only corneal collagen cross-linking (CXL) therapy approved in the US has gained an additional indication. Read more »

Broccoli-related compound a possible AMD treatment

Researchers are investigating a broccoli-related compound as a potential treatment for age-related macular degeneration (AMD).

Read more »

Lifting freeze on patient rebates should be first priority: AMA

The head of the Australian Medical Association (AMA) has indicated that lifting the Medicare rebate freeze should be one of the first priorities of the re-elected Federal Government. Read more »

Vision 2020 appoints new CEO

Vision 2020 Australia has appointed Ms Carla Northam as its chief executive officer. Read more »

New dry-eye product to take on Allergan

The recent US FDA approval of a new dry-eye product could spell increased competition for global pharmaceutical giant Allergan. Read more »

Valeant loses major shareholder

Struggling Canadian drug manufacturer Valeant Pharmaceuticals has lost the support of a major shareholder. Read more »

Blood-sugar test price hike could impact diabetes control

A hike in the price of blood-sugar tests used by diabetics could potentially lead to an increase in eye problems. Read more »
Simon Hanna, Optometry Australia national clinical policy advisor

Therapeutic ingredients to be renamed

The Federal Government is updating several medicine ingredient names, which may affect the labelling of ocular therapeutics. Read more »


Hot Stories


Subscribe for Insight in your Inbox

Get Insight with the latest in industry news, trends, new products, services and equipment!